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Early embryo development in humans is a complex process. Due to recent advances in
research, many improvements have been made in in vitro-fertilization (IVF) outcomes.
Success has been credited to the application of comprehensive chromosome screening
(CCS) however, not every euploid embryo will always implant due to various outside
factors (1). More reproductive markers would need to be evaluated to optimize the success
of implantation of euploid embryos.
MiRNAs are emerging as important regulators of cellular differentiation and may be
involved in the human pre-implantation process. Any dysregulation of microRNA
expression may play an important role in the progression or to other factors involving
infertility. MiRNAs may have the potential to be a maker for embryonic reproductive
competence. This study aims to develop and validate a new methodology in which both
miRNA and CCS can be evaluated from the same trophectoderm biopsy.

In this study, two miRNA complimentary DNA (cDNA) synthesis strategies (the Megaplex
Synthesis kit and the TaqMan Advanced miRNA cDNA synthesis kit) were tested on 5cell or 7-cell samples from two human fibroblast cell line (GM00323) and (GM01359) to
establish the validity of the methods. RNA purified from large amount of cells was also
tested to serve as a gold standard. MicroRNA expression was assessed by Real-time
quantitative polymerase chain reaction (RT-qPCR) and next-generation sequencing
(NGS). CCS was performed simultaneously by previously established platforms (targeted
NGS and PCR24).
The miRNA expression from 5-cell samples showed inconsistent results to purified RNA
by using the Megaplex Synthesis kit and qPCR. The short length and similarity of miRNAs
sequence make the alignment of NGS reads difficult for bioinformatics analysis. Better
results were obtained using the TaqMan Advanced miRNA cDNA synthesis kit, which also
have the advantage to detect novel miRNA in future. The synthesized cDNA was pre
amplified with miRNA primers and previously validated CCS primers. The expression of
the three miRNAs was detected in 7-cell samples and bulk total RNA. PCR24 CCS showed
100% consistency with the expected karyotypes. More samples will be needed to be
processed to improve the consistency. Once this method for simultaneous CCS and miRNA
analysis has been established, it can provide a foundation for the development of miRNA
biomarkers of reproductive potential.
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Introduction
Infertility is a common problem that affects many couples attempting to get
pregnant. It affects about 8-12 percent of couples worldwide (14). Infertility can be due to
either the woman, the man or potential other unknown issues. Many risk factors come into
play such as women’s ovulation problems, stress, diet, and age being one of the most
known culprits. Assisted reproductive technology (ART) over the past two decades has
aided in helping couples become pregnant over the years. ART refers to the process when
a woman’s eggs get removed, mixes with the partner’s sperm to make the embryos to later
be put back into the woman’s body. Success rates vary depending on the type of ART
which consists of in vitro fertilization, zygote transfer, and other treatments. The downfall
of such treatments is the invasiveness, the expensive cost, along with the emotional and
physical strain on the woman.
As technology advances, scientists and clinicians have had to adapt to stay on top
of current advances in ART. However, researchers cannot rush to adopt new technologies
without proper preclinical validation especially in such sensitive cases such as infertility
issues (15). For the past decade, research has evolved along with new innovations and
technology. Scientists have been attempting to find easier, less non-invasive strategies to
better detect early signs of disease or infertility (16). This has led to research in attempt to
find easier or low-cost reproductive testing, reproductive biomarkers and other fertility
services. Research specifically in the reproductive medicine studies has taken a large focus
on early embryo development which is one of the most critical and complex parts of the
pregnancy process.
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In humans, early embryo development is a complex process that consists of
sequential events: oocyte maturation, fertilization, embryonic growth, and implantation.
Any disruption of these highly regulated processes result in infertility and reproductive
failure. Due to advances in clinical and laboratory practice, improvements have been made
in in vitro fertilization (IVF) outcomes. This success has increased greatly with the
application of comprehensive chromosome screening (CCS) (1). However, not every
transferred euploid embryo results in implantation because failure may be related to
inherent embryonic quality that is beyond genetic composition, endometrial receptivity or
other complex interactions between these factors. More reproductive markers would be
evaluated in optimizing success of euploid embryo transfers.
The potential for more reproductive biomarkers could be used for timely detection
of diseases along with early identification of individuals for prevention of diseases (5). A
reproductive marker has the possibility of being used to aid in the evaluation of exposure,
identification of groups that are vulnerable to treatment, predicting outcomes of health and
implantation (5). With the potential of numerous biomarkers being candidates, there is still
only a very small number of new molecular entities entering clinical trials for reproductive
medicine. In reproductive medicine, there are still many unknowns which may take a while
until they can be unraveled. With the use of next generation sequencing (NGS), single
nucleotide polymorphisms (SNP), real-time quantitative polymerase chain reaction (RTqPCR) along with microarray analysis, there is trend among these tools in their ability to
analyze many targets at once which could hold the key to advancements in the discovery
and complexity of new biomarkers in reproductive medicine (6).
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MicroRNAs are important cytoplasmic components that have the potential to be a
valuable bio-marker for reproductive competence. MiRNAs are single-stranded, non
coding RNA molecules containing about 22 nucleotides in length that function in posttranscriptional regulation of gene expression by silencing mRNA translation of promoting
its degradation in the cytoplasm (2). MiRNAs can be detected in various bodily fluids such
as blood, urine, amniotic fluid and etc. It has been shown that human blastocysts express a
large number of miRNAs. They can be secreted and found in embryo culture media. There
have been efforts made to be able to profile and connect specific miRNAs that have been
discovered in medium along with embryo ploidy status. Along with the reproductive
competence to predict IVF outcomes (26). In studies that will be later discussed, several
candidates of miRNA profiling have been identified. However further studies need to be
implemented in order to allow a comprehensive, overall profiling of microRNAs due to
secretion of human pre-implanted embryos (26). In reproduction, miRNA is involved in
the regulation of several biological processes, such as follicular cell proliferation and
apoptosis, oocyte maturation, embryogenesis, and implantation. They work to maintain a
balance among pluripotency and differentiation in the embryo. It has become apparent that
any dysregulation of miRNA expression may play a crucial role in the progression and
factors related to infertility (3). MiRNA hold high potential to be used for the prognosis,
therapy, and biomarkers related to infertility (3,4).
MicroRNAs play an important role in regulating gene expression with fundamental
roles in different reproductive biological processes. Their role in silencing genes, stems
from them directing target messenger RNA (mRNA) degradation or translational
repression (7). It is known that the epithelial cells of the uterine glands and lumen undergo
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cyclic changes when under the influence of sex steroid hormones estradiol-17beta (E2) and
progesterone (P4). The human endometrium undergoes such changes due to direct
regulation by these hormones. E2 produces a surge of uterine epithelial cell proliferation
which ultimately promotes differentiation along with effects on the endometrial stroma
later on in the secretory phase. Based on the research from Albert Einstein College of
Medicine, coordinated action of E2 and P4 is essential for controlling proliferation of the
endometrium and for the potential of uterine receptivity at the time of embryo transfer
during implantation (7). This would hold prospective for successful implantations if
microRNA could be identified as a potential identifier of molecular mechanisms involved
in normal hormonal regulation of the human endometrium. This would be a step towards
the understanding of molecular deregulation occurring at the time of implantation along
with the possibility of revealing different novel therapeutic opportunities for reproductive
medicine (7).
Due to previous studies proving there is a miRNA expression in the human
endometrium, it is important to now study whether these miRNAs play an actual role in
any modulation or variation on the expression of different hormonal genes. This leads to
the prospect that if any advancements can be made in profiling the different miRNAs found
at the time of implantation or so on can hold great hope for more successful transfers and
embryo implantations (7).
As of today, over 1,000 miRNAs have been identified in the human genome and
are considered to be major transcriptional regulator of gene expression. The role of miRNA
can alter the levels of different target genes at the 3’ untranslated regions (UTRs) of
mRNAs and partial sequence complementation, along with mRNA stability and protein
11

translation (8). MiRNAs get secreted in membrane bound exosomes and then attach to
stabilizing protein which can be detected in all body fluids as well as in culture media of
cell lines. Studies have shown that they believe miRNAs that get released from donor cells
can then be taken into recipient cells. This is where the miRNAs might have the ability to
use their genetic regulatory function of their own. This brings about an idea that miRNA
has the possibility of exerting its own functions and actions once secreted (8).
In one particular study by Chen et al. blood serum samples were taken and based
on results it showed that the miRNAs that were found were highly stable were able to
survive various environmental settings such as constant freezing and thawing (9).
Therefore, based on that study it was apparent that miRNA had the potential to be an
effective biomarker. This finding brought upon a huge interest in studying and identifying
miRNAs found in different fluids that could be used in a non-invasive manner to test for
different diseases early on. Studies have shown that particular miRNAs such as miR141,
miR-499, and miR-122 can be seen to be involved in cancer detection in blood, myocardial
infarction, and other liver diseases (9-13). It’s possible that specific miRNAs can be seen
and secreted in the extracellular environment specifically in contact with the blastocyst to
endometrium. This is an important relationship that is necessary for proper implantation to
occur (9).
In order for a successful implantation, the blastocyst-endometrium interaction is
very important and could determine if the environment is fit for the potential embryo at its
implantation site (9). This has led to a growing interest in the past few years regarding
potential biomarkers based on this blastocyst-endometrium interaction. MicroRNAs may
be the key to becoming the newest emerging reproductive markers and therapeutic
12

innovations for understanding and testing why implantation fails (17). Recently in multiple
studies, microRNA has arose as a subject of interest as a potential reproductive biomarker.
Several recent studies have shown that the human endometrial epithelium releases
exosomes into the uterine opening and potentially those exosomes could be moving their
substances to either the endometrium or the blastocyst (18, 19). This kind of interaction
could influence a number of things in the endometrium-blastocyst relationship. Leading to
an influence on implantation potentially by affecting the endometrium’s gene expression
(18, 19).
A key to sustaining and developing a healthy implantation and pregnancy, a
receptive endometrium is required. Based on numerous studies, the formation of the
endometrium receptivity is a highly complicated procedure for being known as a spatially
and temporally restricted occurrence in the secretory phase of menstruation known as the
ideal time for implantation (20). The endometrium is known to be under epigenetic
regulation (21). Several studies have shown that numerous genes are being expressed in
the endometrium along with being recognized as gene regulatory networks. Several
miRNAs have also been recently classified in the human endometrium as well (20).
Any imbalance in the endometrium process in the receptive stage has been shown
to be a main cause of infertility. Anything that goes wrong during this phase has been
known to lead to failure of implantation and infertility. This can be seen even in ART,
where embryos that are classified as of healthy and good quality upon transferring, fail to
implant correctly. This has been seen to be due to any improper uterine receptivity after
the transferring of the embryo (20). This can be frustrating for couples who spend
thousands of dollars to make sure their embryos are selected for quality and reassurance
13

for implantation. However, outside factors are to blame such as endometrium and uterine
receptivity of the embryo. The list of different factors and issues that can play a role in a
woman’s success of pregnancy is based on many factors regarding health, genetics, and
etc.
During the phase discussed earlier, the endometrium holds power to permit the
attachment and presence of an embryo. This phase is very critical because if the
endometrium denies the presence of the embryo, a successful implantation will not occur
(20). A better understanding of why the embryo gets rejected by the endometrium could
lead scientists and medical professionals in the right direction to understanding more of
why this happens. This is what brings up reproductive biomarkers over and over again in
recent studies. Many molecular studies have extensively studied the expression and
regulatory factors involved with uterine reception along with lists of possible molecular
entities and genes that may be involved in creating a better reception of the endometrium.
Despite the increase in interest, little to none has been still understood what molecular
mechanisms are regulating these gene expressions (20).
MicroRNAs hold the potential to be the key to unraveling the molecular
mechanisms occurring in the endometrial receptivity. Despite being very small of about
only 22 nucleotides, a single miRNA can potentially regulate more than a hundred of
mRNA targets (20). Even though only 1000 miRNAs have been discovered in humans,
studies suggest that there could be up to thousands of potential miRNAs that are targeting
over 60% of human genes. This finding shows that miRNAs have the potential and ability
to compose a variety of different cellular and biological process in human specifically
change in the female reproductive tract (20).
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Results previously have shown that there has been involvement of miRNAs in the
murine uterus during embryo implantation in studies by Hu et al and Chakrabarty et al (22,
23). Previous and current studies show that miRNAs hold the potential to be reproductive
biomarkers for the future. In another recent study, patients undergoing IVF in natural and
stimulated cycles, miRNAs were proposed as potential biomarkers of the endometrium’s
receptivity (24).
In addition, another study focusing on miRNAs, a select number of women who
suffered numerous implantation failures were studied. The study’s researchers were able
to detect the disease-specific miRNAs for identification. These miRNAs hold the potential
to be viewed as new contenders for diagnosis and treating failure of embryos implanting
(25). With the use of TaqMan miRNA array cards, the study was able to identify the
miRNAs associated with being expressed in the secretory endometrium of repeated
implantation failure patients in comparison to fertile patients. As discussed previously, the
main concern is that the ability of endometrial receptivity occurs correctly with no issues.
Days 20 to 24 of a regular menstrual cycle are some of the most crucial days for proper
adhesion of the embryo. It’s known that the endometrium will undergo gene expression
changes under action of different hormones (25).
Based on the previous study, evidence has shown that the hormones estrogen and
progesterone regulate the endometrium’s expression of various regulator known to include
growth, cytokines, and chemokines and so on. These factors serves as main components of
the implantation process (27). In order for proper implantation, the endometrial expression
of such molecules must be synchronized in a timely manner. However, it is still unknown
if during this time frame, critical genes are not being properly expressed which explains
15

why implantation may be potentially occurring correctly. There is still so much to be
understood regarding these molecular mechanisms regulating expression of certain genes
(27). In this specific study, 10 miRNAs were identified and overexpressed with only 3
miRNAs being under expressed. This particular study allowed the opportunity for miRNA
expression profiling in order to distinguish which specific mRNAs may be posttranscriptional ly repressed by miRNAs (28). In our own specific study, we have chosen to
study six specific genes that have been validated to be found in fibroblast cell cultures
previously.
Despite there still being a lot of room for research and innovations, the use of such
reproductive biomarkers holds potential. The use of microRNA profiling in blastocyst and
embryo implantation can be possibly a key to successful pregnancies. Reproductive
biomarkers such as microRNA are a great way of hypothetically improving the chances of
a woman’s chance of pregnancy. In the current study, we hypothesize that by establishing
a method of miRNA profiling in addition to CCS testing in the same trophectoderm biopsy
will allow miRNA to be a potential embryonic biomarker.
All of these previous studies have brought on an emerging interest to focus on
profiling microRNAs for embryo implantation. The main techniques that are currently
being used to measure and profile miRNA expression are RT-qPCR, microarray and next
generation sequencing (NGS). Samples of 5-cell or 7-cell from two human fibroblast cell
line (GM00323) and (GM01359) were picked and lysed to establish the validity of the
methods. RNA purified from large amount of cells was also tested to serve as a gold
standard. To test and validate this, two strategies using complementary DNA (cDNA)
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synthesis methods were selected along with platforms such as NGS, RT-qPCR, and PCR
24 to further study this.
The first strategy implemented was a cDNA Synthesis with Megaplex Primers
(Thermo Fisher Scientific, CA, USA). The Megaplex cDNA synthesis reaction offers a
reverse transcription (RT) of over 450 miRNAs, allowing for a high throughput profiling.
This strategy targets these miRNAs and covers a range of quantification (29). It involves a
RT step where the cDNA is reverse transcribed from miRNA samples using specific
miRNA primers and reagents. The pre-amplification step then uniformly amplifies the
cDNA samples. The second strategy used was the TaqMan Advanced miRNA cDNA
Synthesis Kit which uses a reverse transcription (RT) chemistry to create a cDNA template
to use along with Advanced MiRNA Assays (Thermo Fisher Scientific, CA, USA).
This strategy allows for thorough detection and quantification of miRNAs in
samples. This method has been previously adapted in numerous studies and has shown to
be a potential approach to profile miRNAs. This synthesis kit includes a poly (A) tailing
where a 3’ adenosine tail is added to the miRNA using a poly (A) polymerase. The miRNA
undergoes an adaptor ligation at the 5’ end. This adaptor plays a role as the forward primer
binding step, then a universal RT primer binds to the 3’ poly (A) tail to reverse transcribe
the miRNA creating cDNA. A pre-amplification step is then done where a universal
forward and reverse primer are used to increase the number of cDNA molecules.
Accurate high-throughput profiling of miRNAs is still a major challenge. In this
study, we will focus on three main platforms including NGS, RT-qPCR, and PCR 24. RTqPCR was chosen for its reliability and superior sensitivity to be able to profile known
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mature miRNAs (29). PCR 24 similarly to RT-qPCR is a PCR based methodology that
allows for aneuploidy screening simultaneously. NGS which has been shown only most
recently in studies, can not only profile known miRNAs such as RT-qPCR but it is also
can identify unknown miRNAs which beyond the capabilities of RT-qPCR. NGS holds
high potential for different applications to profile miRNAs and is progressing rapidly (30).
Methods
Experimental Design
The aim of this study was to validate a method of profiling microRNAs with
comprehensive chromosome screen testing simultaneously in 5-fibroblast cell samples
which was later changed to 7-fibroblast cell samples to mimic a trophectoderm biopsy a
laboratory would receive for CCS testing (Figure 1). The fibroblast cell samples were
tested to establish microRNA as a potential marker for reproductive competency in
patients. Two strategies were chosen to test cDNA synthesis protocols to prepare cDNA
templates for testing. In the first strategy, cDNA synthesis was done using Megaplex
primers (Thermo Fisher Scientific, CA, USA). NGS and RT-qPCR was implemented to
profile microRNAs using stringent examination of cell-specific miRNA profiles as well
discovering uncharacterized miRNAs. In the second strategy, the TaqMan Advanced
MiRNA cDNA synthesis kit (Thermo Fisher Scientific, CA, USA) was implemented. RTqPCR, NGS, and PCR24 were used to profile miRNAs based on already known
characterized miRNAs. MiRNA assays were chosen and evaluated to be used on qPCR to
profile already characterized miRNAs in the cell samples.
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1600

Cell Number

Figure 1. Estimated Cell Number in Trophectoderm (TE) biopsies on Day 6.

Cell line samples
Two human fibroblast cell lines GM00323,GM04435, and GM01359 were obtained from
the Coriell Cell Repository (CCR, Camden, NJ) and cultured in Minimum Essential Media
with 2X nonessential amino acids, 15% fetal bovine serum, 1% penicillin-streptomycinglutamine (Invitrogen Corp., Carlsbad, CA, USA) at 37°C and 5% C02. RNA from large
quantities of cells is purified with QIAGEN columns as recommended for cell cultures by
the supplier (QIAGEN Inc., Valencia, CA). Five-to-seven cells are obtained in lui medium
using a dissecting microscope and loaded into PCR tubes to mimic trophectoderm biopsies.
Cell Lysis Using SCTC Lysis Buffer
8.7ul of SCTC lysis buffer (Thermo Fisher Scientific, CA, USA) and 1 ul of SUPERase
(Thermo Fisher Scientific, CA, USA) were combined and then 3ul of that master mix were
added into the PCR tubes above the 0.5 ul of cell. Snap freeze of the samples was done in
liquid nitrogen.
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Cell Lysis Using Invitrogen Lysis Solution
8.7ul of PowerSYBR green lysis solution (Thermo Fisher Scientific, CA, USA) and 1 ul
of SUPERase (Thermo Fisher Scientific, CA, USA) were combined and then 3 ul of that
master mix were added into the PCR tubes above the 0.5 ul of cell. Snap freeze of the
samples was done in liquid nitrogen.
First Strategy: cDNA Synthesis with Megaplex Primers
The Megaplex Primer pools were chosen to detect low expressed miRNAs to generate an
expression profile in our fibroblast samples. The primer pools targeted miRNAs that tend
to be characterized and expressed in humans to be used for analysis on RT-qPCR. A reverse
transcription (RT) master mix (Thermo Fisher Scientific, CA, USA) was combined
consisting of the following components: 2ul of both A and B Megaplex RT Primers (10X),
0.5ul of dNTPS with dTTP (100 mM), 3ul of Multiscribe Reverse Transcriptase (50 U/ul),
2ul of 10X RT buffer, 2.25ul of MgCb (25 mM), and 0.25ul of RNase Inhibitor (20 U/ul).
12ul of the combined RT reaction mix was added to each tube with lysates. The PCR tube
was inverted 6 times to mix and centrifuged. The samples were then incubated on ice for 5
minutes. A run method was created on the Applied Biosystems 2720 thermocycler (Thermo
Fisher Scientific, CA, USA) with conditions set 40 cycles of 2 min at 16°C, 1 min at 42°C,
and 1 sec at 50°C followed by a hold of 5 minutes at 85°C and 4°C.
Preamplification with Targeted NGS and miRNA primers
A primer pool was made with 70ul of each primer pool A, B (Thermo Fisher Scientific,
CA, USA) and universal Rev primers. The following was combined in a 1.5mL micro
centrifuge tube to be added to each to tube of lysates. The PreAmp reaction mix consisted
20

of 50ul of TaqMan PreAmp master mix (2x) and 25ul of the primer pool (3.3X) created. A
targeted barcoded forward primer of 5ul was added to each individual tube. PCR cycling
conditions were set to 10 min at 95°C followed by 18 cycles of 15 sec at 95°C and 4 min
at 60°C on Applied Biosystems 2720 thermocycler (Thermo Fisher Scientific, CA, USA).
Library preparation for NGS
The Ion Xpress Plus gDNA Fragment Library Preparation protocol (Thermo Fisher
Scientific, CA, USA) was conducted. The amplified miRNA was purified with Agencourt
AMPure XP Reagent beads (Beckman Coulter Inc., CA, USA). End repair was done on
the samples by adding 20ul of 5X End Repair buffer and lul of End Repair Enzyme to the
Fragmented RNA. The samples were purified with Agencourt AMPure XP Reagent beads.
A Ligate and Nick-repair was then done by the addition of following components: lOul of
10X Ligase Buffer, 2ul of Ion PI Adapter, 2ul of Ion Xpress Barcode, 2ul of dNTP Mix,
49ul of Nuclease-free water, 2ul of DNA ligase, and 8ul of Nick Repair Polymerase were
added to each individual sample of 25ul of the lysate. A thermocycler program was set up
to run a hold of 15 min at 25°C followed by a hold of 5 min at 72°C with a third hold at
4°C Applied Biosystems 2720 thermocycler.
The amplified miRNA was purified with Agencourt AMPure XP Reagent beads. An
amplification of the samples was done by the addition of the following components: lOOul
of Platinum PCR SuperMix High Fidelity, 5ul of Library Amplification Primer Mix to 25ul
of the unamplified library. PCR cycling conditions were set to 5 min at 95°C followed by
8 cycles of 15 sec at 95°C, 15 sec min at 58°C, 1 min at 70°C and a 4°C hold on Applied
Biosystems 2720 thermocycler. Samples were then analyzed on the Agilent 2200
21

TapeStation by loading lul of your sample preamplification product and 3ul of the loading
buffer into each well of a plate. Samples are then loaded, separated, imaged and analyzed
using the D1000 ScreenTape (Agilent, Santa Clara, California). The amplified miRNA was
purified with Agencourt AMPure XP Reagent beads. The samples were then normalized
and pooled to be run on next-generation sequencing specifically on the personal genome
machine (PGM) (Thermo Fisher Scientific, CA, USA).
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Figure 2. Ideal hypothetical next-generation sequencing result outcome.
Ideally, an accurate chromosome karyotype call would be detected such as in Figure 2 on
the miRNA lysates post library preparation and sequencing on the PGM. This would allow
for proper karyotype calls using CCS testing along with miRNA profiling to be used.
Megaplex Primers MicroRNA (qPCR)
9 miRNA assays were studied and chosen to be run consisting of genes hsa-mir-509-3-5p,
hsa-mir—876-5p, hsa-mir-7a, hsa-mir-7f, hsa-mir-135a, hsa-mir-190, hsa-mir-545, hsamir-758 and an endogenous control U6_snRNA (Thermo Fisher Scientific, CA, USA).
These assays were chosen based on previous experimental results showing detection of
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these miRNAs in other cells and were tested for detection in our fibroblasts. Prior to qPCR,
an ExoSAP-IT (Thermo Fisher Scientific, CA, USA) treatment was performed on 25ul of
the preamplification product with 5ul of the ExoSAP-IT reagent for an enzymatic cleanup
of amplified PCR product. Then, 2ul of the preamplification product is added to 0.5ul of
each individual miRNA assay with 2.5ul of GEX master mix (Thermo Fisher Scientific,
CA, USA) 5ul of the mixture is loaded into each port of the 384 plate, followed by
centrifuge and plate sealing. RT-qPCR is performed on applied ABI 7900HT instrument
(Thermo Fisher Scientific, CA, USA).

TaqMan MiRNA Assays
U6_snRNA
Hsa-mtr-509-3-5p
Hsa-mir— 876-5p
Hsa-mir-7a

Hsa-mir-7f
Hsa-mir-135a
Hsa-mir-190
Hsa-mir-545
Hsa-mir-758

Table 1. TaqMan miRNA Assays chosen to be used for qPCR.
Strategy 2: cDNA synthesis with Advanced TaqMan miRNA Assays
The TaqMan Advanced miRNA cDNA Synthesis kit works by using a 3’ poly-A tailing
and 5’ ligation of adaptor sequence to extend miRNAs existing in each sample prior to
reverse transcription (RT). The universal RT primers then recognize the universal
sequences present on both the 5’ and 3’ extended ends of the miRNAs. Then, all miRNAs
23

currently in the sample are reverse transcribed to cDNA. An amplification step is done
using the Universal miR-Amp primers and miR-Amp Master Mix to increase the amount
of cDNA for each target to maintain expression levels. (Thermo Fisher Scientific, CA,
USA).
A Poly (A) tail reaction (Thermo Fisher Scientific, CA, USA) is performed by the addition
of Poly-(A) reaction mix consisting of 0.5ul of 10X Poly(A) buffer, 0.5ul of ATP, and 0.3ul
of Poly(A) enzyme. 3.0ul of the combined Poly-(A) reaction was added to each tube with
lysates. The PCR tube was vortexed briefly and centrifuged to spin down the contents and
eliminate air bubbles. A run method was created on the Applied Biosystems 2720
thermocycler (Thermo Fisher Scientific, CA, USA) with conditions set to 60 minutes at
37°C for polyadenylation and 10 minutes at 65°C to stop the reaction followed by a hold
at 4°C. Proceeding after the addition of the Poly-(A) tail, an adaptor ligation reaction was
performed.
A ligation reaction mix was made consisting of 3ul of 5X DNA ligase buffer, 4.5ul of 50%
PEG 8000, 0.6ul of 25X ligation adaptor, 1.5ul of RNA ligase, and 0.4ul of RNase-ffee
water. lOul of the total ligation reaction master mix after being vortexed and centrifuged
was added to each tube with the lysates. The samples were vortexed briefly to mix the
contents and centrifuged to spin down the contents. PCR cycling conditions were set to 2
hours at 16°C for ligation followed by a hold at 4°C.
A reverse transcription (RT) reaction was then performed by the addition of 6ul of 5x RT
Buffer, 1.2ul of dNTP mix (25mM each), 1.5ul of 20X Universal RT Primer, 3ul of 10X
RT enzyme mix, and 3.3ul of RNase-free water. The RT reaction mix was vortexed and
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centrifuged briefly. 15ul of the total RT reaction mix was added to each reaction tube then
vortexed briefly and centrifuged to spin down contents. PCR cycling conditions were set
to 15 minutes at 42°C for reverse transcription, 5 minutes at 85°C to stop the reaction
followed by a hold at 4°C. MiR-Amplification reaction was then performed by the addition
of 30ul of 2X miR-Amp master mix, 2.5ul of 20X miR-Amp primer mix, 2.5ul of barcoded
CCS forward primer, and 2.5ul of CCS reverse primer.
Library preparation for NGS
Post Advanced TaqMan miRNA cDNA synthesis, samples were analyzed on the Agilent
2200 TapeStation by loading lul of your sample preamplification product and 3ul of the
loading buffer into each well of a plate. Samples are then loaded, separated, imaged and
analyzed using the D1000 ScreenTape (Agilent, Santa Clara, California). The amplified
miRNA was purified with Agencourt AMPure XP Reagent beads. The samples were then
normalized and pooled to be run on the Ion Chef system to be prepared to run specifically
on the Ion Proton instrument (Thermo Fisher Scientific, CA, USA).
TaqMan® MicroRNA (qPCR)
Similarly to the methods described previously, RT-qPCR was done using the
preamplification products from cDNA synthesis using the TaqMan Advanced miRNA
Assays. The six miRNA assays were implemented in this strategy (Table 2). Protocol was
carried out the same as described previously. These assays were chosen due to being more
compatible with our TaqMan cDNA synthesis kit which improved methodology.
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TaqMan Advanced nuRNA Assays
t-16 (endogenous control)

hsa-let- 7b-4395446

hsa-miR-99a-4373008
hsa-miR-181 a-43 73117
hsa-miR-574-3p-4395460

Table 2. TaqMan Advanced miRNA Assays chosen to be used for qPCR.
PCR 24
A preamplification is first performed by the addition of 25ul of TaqMan PreAmp Master
Mix, 12.5ul of the PCR24 PreAmp Primer Pool, and 2.5ul of molecular biological grade
water (MBG) to each miRNA lysate. The PCR 24 master mix is then vortexed and
centrifuged. 40ul of the reaction master mix is then added to side of each tube. The samples
are then spun, vortexed and spun again. A run method was created on the Applied
Biosystems 2720 thermocycler (Thermo Fisher Scientific, CA, USA) with conditions set
to 10 minutes at 95°C for enzyme activation, 18 cycles of 15 seconds at 95°C, and 4
minutes at 60°C followed by a hold at 4°C. Plates were then registered to be run on the
qPCR 7900. Preparation of 15ml for each sample was done by adding 1.25ml of GEX
master mix (Thermo Fisher Scientific, CA, USA) and 1.2ml of MBG water in a 15ml tube.
A real time PCR was set up, once the preamp was finished it was added to the 15ml tube
with the GEX master mix and water. The tube was then vortexed and centrifuged. The
mixture was poured into a reservoir and 5ul was added into each well of the prepared dried
assay plate for PCR 24 using an auto- 12-channel P I00 multipipetter by adding the mixture
on the side of each well. The plate was then run on the qPCR 7900 instrument.
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A U T O C a ll: 46,XX

L a b (N A ):N A

R E S U L T : L o c k e d r s z (46,XX )

Chromosome if * appears exceeds concordance threshold 0 49

Figure 3. Ideal hypothetical PCR 24 CCS result outcome.
Ideally a correct chromosome karyotype call would be detected such as in Figure 3 but on
the miRNA lysates post PCR24 preamplification and PCR. This would allow for proper
karyotype calls to be made for chromosome screening along with the ability to profile
miRNAs simultaneously.
Results
Strategy 1: Megaplex Primers cDNA Synthesis
TapeStation Results
Initially, 5-fibroblast cell samples were used and cDNA was prepared using the Megaplex
synthesis protocol and sequencing libraries were quantified on TapeStation for analysis.
The TapeStation results analyzed and quantified the size specific amplicons. All seven
samples appeared to show a band around the same base pair mark including our purified
RNA sample and negative control (NTC) (Figure 4). The NTC appeared to reveal a band
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around the same base pair mark with possibilities that amplification was occurring from
possibly the enzymes used in the CDNA kit or other sources. Sequencing was performed
on ION PGM. The chip loading and final library reads passed manufactory suggested QC
(Figure 5). In the sequencing results, over 93% of the reads were not able to be aligned to
short miRNA references before trimming. The sequencing reads from 0323 5-cell were
aligned to long endogenous control U6 gene (Figure 6). The NTC didn’t show alignment
to U6 gene as expected therefore proving it was not detecting miRNAs (Figure 7). It was
impossible to trim the primer sequences due to each miRNA having different primers
(Figure 6).
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1

2

3

4

5

6

7

Lane M: Ladder
Lane i : 0323 sample
Lane 2: 0323 sample
Lane 3: 4435 sample
Lane 4: 4435 sample
Lane 5: 0232 Total RNA
Lane 6: 4435 Total RNA
Lane 7: NTC

Figure 4. TapeStation quantification of miRNA samples after cDNA synthesis using
Megaplex Primers.
NGS Results
50 bp

Read Length

Figure 5. Sequencing results on PGM.
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Figure 6. Alignment results of U6 endogenous control gene of 0323 5-cell sample.

Figure 7. Alignment results of U6 endogenous control gene of NTC.
QPCR Results
QPCR results for the Megaplex Synthesis samples did not show any detection or expression
amongst the 9 TaqMan Assays (Table 1). There was undetermined CT values for the
samples.
Strategy 2: TaqMan Advanced MiRNA cDNA Synthesis
CDNA were synthesized using TaqMan Advanced miRNA kit for 7-cell samples lysed by
SCTC lysis buffer from cell line GM00323, and then pre-amplified with miRNA primers
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and previously validated targeted NGS CCS primers. The libraries were assessed by
TapeStation DIK kit (Figure 8). 7-cell samples and total bulky RNA showed small miRNA
amplicons. However, the NTC samples also showed the same amplification. 7-cell samples
showed their amplicons around the 200bp, which were the tNGS CCS amplicons. The total
purified RNA and NTC did not show amplification in the targeted regions as expected.
TapeStation Results

M

1

2

3

4

Lane M: Ladder
Lane 1: 0323 sample
Lane 2: 0323 sample
Lane 3: 0323 Total RNA
Lane 4: NTC

Figure 8. TapeStation quantification results after cDNA synthesis using TaqMan Advanced
miRNA kit.
tNGS CCS was performed on the 7-cell samples, and showed non-concordant results
because of the high MAPD, which measures the quality of concordance of the copy number
estimation from different loci on the same chromosome (Figure 9 and Figure 10).
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NGS Results
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Figure 9. Next-generation Sequencing Results with CCS for sample 0323 1

Figure 10. Next-generation Sequencing Results with CCS for sample 0323 2.

QPCR was performed on the cDNA from 7-cell samples and bulky RNA with the six
TaqMan Advanced miRNA assays. The CT’s were either non-determined or very high,
indicating there was little to no detection of those miRNAs (Table 3).
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QPCR Results

D etector N a m e

323_20

3 2 3 .2 1

Total Purified R N A

NTC

hsa-m¡R-16-5p

34.91

36.72

36.15

Not Determined

hsa-let-7b-5p

33.85

32.54

27.8

Not Determined

hsa-m¡R-181a-5p

32.76

35.22

30.11

Not Determined

h$a-m¡R-222-3p

34.34

31.97

31.86

Not Determined

hsa-miR-574-3p

Not Determined

Not Determined

Not Determined

Not Determined

hsa-m¡R-99a-5p

Not Determined

Not Determined

Not Determined

Not Determined

Table 3. QPCR delta cycle threshold (CT) values after cDNA synthesis using TaqMan
Advanced miRNA kit.

Stop solution may interfere the downstream amplification, therefore, lysis was performed
on 7-cell samples without stop solution, and followed by Advanced miRNA cDNA
Synthesis with modified conditions. Similar amplification was observed from the
TapeStation D lk kit. The red boxes in figure 10 show the faint band where our small
miRNA amplicons appear similarly to figure 7 (Figure 11).
TapeStation Results

M

1

2

3

4

Lane
Lane
Lane
Lane
Lane

M Ladder
1: 0323 sample
2: 0323 sample
3: 0323 Total RNA
4: NTC

Figure 11. TapeStation results without stop solution in the lysis procedure.
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tNGS CCS was performed on the 7-cell samples treated without stop solution, and showed
non-concordant results because o f the high MAPD, which measures the quality of
concordance of the copy number estimation from different loci on the same chromosome
(Figure 12 and Figure 13).
NGS Results

0323 1

Figure 12: Next-generation Sequencing Results with CCS for sample 0323 1.

□-------------------------------------- ------ □--------------------------------—— ----- a

Figure 13: Next-generation Sequencing Results with CCS for sample 0323 2.
The qPCR was performed on the 7-Cell samples and bulky RNA. hsa-let-7b-4395446,
hsa-miR-222-4395387, and hsa-miR-18 la-4373117 showed expression on all the
samples. The delta cycle threshold (CT) was calculated for each sample using hsa-miR-
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16-5p as the endogenous control. The delta CT was done by being subtracted from the
endogenous control in reference to each miRNA assay run. 7-cell samples showed
consistent expression levels with bulk total RNA (Figure 14).
QPCR Results
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hsa-m iR - 2 2 2 - 3 p
2

m

Total
RNA

HI
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I
-12

Figure 14. QPCR results of Delta CT values using miRNA assays (a) hsa-let-7b-5p, (b)
hsa-miR-181a-5p, and (c) hsa-miR-222-3p.
PCR 24 Results
PCR24 was performed for CCS to remove batch effect. Compared to the ideal PCR 24
results (Figure 3) shown previously, the PCR 24 results for cell line sample 0323 were no
concordant (Figure 15). In conclusion, 7-cell samples lysed using SCTC lysis buffer
failed to detect the karyotypes.
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Pat # 0
Name. miRNA
Proc/Job # 0
Date: 04/22/2017
SamplelO: miRNA_323.10
Embryo # 0
PlatelD: MIRNA_323_10.04222017
NR:miRNA_042017_V2
InterChrSD: 0.42
EstCellCount: 140
Cncrd: 0.5
AUTOCall: nonconcurrent Lab (NA):NA
RESULT: Unlocked (nonconcurrent)
PLV2/COV2 Copy Number/Chr w/StdErr on assays/chr. Zscores are SO counts from std XYrefs

Chromosome if * appears exceeds concordance threshold 0.49

Figure 15. PCR 24 Results for cell line 0323 miRNA samples using the SCTC lysis
buffer and SUPERASE for lysis and the TaqMan miRNA cDNA Synthesis kit.
PowerSYBR Green Lysis solution
The PowerSYBR green lysis solution was tested. The same three miRNAs (hsa-let-7b-5p,
hsa-miR-222-3p, and hsa-miR-574-3p) were detected by qPCR in 7-cell samples and
bulk total RNA. The delta Ct was calculated by using hsa-miR-16-5p as the endogenous
control, and the delta delta Ct was calculated by using normal cell line 0323 as reference
(Figure 16).
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QPCR Results
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Figure 16. Delta delta CT values using miRNA assay (a) hsa-let-7b-5p, (b) hsa-miR-2223p, and (c) hsa-miR-574-3p using the PowerSYBR green lysis solution and SUPERase
for lysis and the TaqMan miRNA cDNA Synthesis Kit.
CCS results from PCR 24 showed 100% consistency with expected karyotypes for both
the euploid and aneuploid cell lines. (Figure 17 and Figure 18). This result showed that
using the PowerSYBR green lysis solution and SUPERASE for lysis and the Advanced
miRNA cDNA Synthesis kit worked ideally to obtain expected karyotype calls for both
cell lines used. (Figure 17 and Figure 18).
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PCR 24 Results
P a t# 0
Name: miR NA
Proc/Job # 0
Date: 04/30/2017 SampM O. mlRNA_1 _0323_4
Em bryo # 0
PlatelD: MIRNA 1 0323 4 04302017
NRrmiR NA 042017 V3 In terC hrSD : 0.31 EatC allC ount: 39 C ncrd 0.17
AUTOCaB: 46,XY
Lab (NA):NA
RESULT: U nlocked (46.XY)
________
■
PLV2/COV2 C opy N um ber/Chr w /StdErr o n a » *a y */ch r Zscores are SD c o u n t* from * td XYref* I
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Chromosome if * appears exceeds concordance threshold 0 49

Figure 17. PCR 24 Results for cell line 0323 miRNA samples using the PowerSYBR
green lysis solution and SUPERase for lysis and the TaqMan miRNA cDNA Synthesis
Kit.
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Figure 18. PCR 24 Results for cell line 1359 miRNA samples using the PowerSYBR
green lysis solution and SUPERase for lysis and the TaqMan miRNA cDNA Synthesis
Kit.
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Discussion
In this study, we have begun to develop and validate a method of miRNA profiling
along with CCS simultaneously to be able to establish miRNA as a marker for reproductive
competence in IVF patients. In order for proper validation, profiling of microRNAs from
7-fibroblast cell samples would be compared to purified RNA from the same cell cultures.
We found that using the PowerSYBR green lysis solution and the second synthesis strategy
the TaqMan Advanced miRNA cDNA synthesis compared to the Megaplex Synthesis
worked ideally. Our PCR 24 CCS and qPCR results indicated that we were able to make
more accurate karyotype calls and detect expression of miRNAs simultaneously (Figure
15, Figure 16 and Figure 17).
In the initial experiments 5-fibroblast cell samples were used which showed
inconsistent results to the purified RNA using the first strategy Megaplex Synthesis kit on
qPCR. Due to the short length and similarity of miRNAs sequences, and different primers
for each amplicons, NGS reads were very difficult for alignment and trimming. With the
second strategy, the TaqMan Advanced cDNA synthesis along with previously validated
CCS primers allowed us to obtain better results with increased detection and expression
levels of miRNAs on qPCR (Figure 13). We believed this could have been due to higher
amplification efficiency of TaqMan Advanced cDNA synthesis kit. Another advantage is
that all the miRNAs are amplified, allowing us the ability to detect novel miRNA in the
future. Our next modification was to test a second lysis buffer to test if the lysis step was
playing a role in why our results were not ideal. We discovered that by switching lysis
buffers and using PowerSYBR green lysis solution and eliminating the stop solution added
towards the end of lysis allowed for us to acquire better results. The expression of the three
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miRNAs was detected in 7-cell samples and bulk total RNA (Figure 15). With these
modifications, we were able to simultaneously have better detection and expression levels
of miRNAs and PCR24 CCS showed 100% consistency with the expected karyotypes
(Figure 16 and Figure 17).
Future studies will aim to further test modifications and different protocols to better
profile miRNAs and simultaneously perform CCS testing. This will provide an opportunity
to investigate any other alternative methods of lysis buffers that could play a role in
allowing this study to progress in validation. Another area of investigation stemming from
the present study would be to test and utilize an RNA Spike-in mix (Thermo Fisher
Scientific, CA, USA). Implementing a RNA Spike-in mix could help eliminate any
interference occurring in the samples. A RNA Spike-in mix could control for different
sources of variability such as the quality of starting material, level of cellularity, and the
platform or system being implemented.
For future research, more samples would have to be run and processed to improve
the consistency of these results. It would be beneficial to possibly test this strategy on
discarded embryos for research to better validate the development of a potential biomarker
such as miRNA. Once this method for simultaneous CCS from 7-cell samples which may
be applied to trophectoderm biopsy and miRNA analysis has been established, it can
provide a foundation for the development of miRNA biomarkers of reproductive potential.
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